Related Experiment Video
Updated: Sep 21, 2025

2 in 1: One-step Affinity Purification for the Parallel Analysis of Protein-Protein and Protein-Metabolite Complexes
Published on: August 6, 2018
Miniproteins in medicinal chemistry
Agnieszka Ciesiołkiewicz1, Juan Lizandra Perez1, Łukasz Berlicki1
1Department of Bioorganic Chemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.
Miniproteins offer promising drug scaffolds due to their defined structure and synthesis. New de novo design methods enable the creation of miniproteins to target previously undruggable proteins.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Drug Discovery
Background:
- Miniproteins are emerging as versatile scaffolds for drug development.
- Their well-defined structures and synthetic accessibility make them attractive candidates.
- Recent advancements in de novo design have expanded their potential.
Purpose of the Study:
- To review methodologies for developing miniprotein scaffolds.
- To outline strategies for constructing biologically active miniproteins.
- To highlight the potential of miniproteins in targeting challenging biological targets.
Main Methods:
- Review of recent literature on miniprotein design and synthesis.
- Analysis of de novo design methodologies.
- Case studies of biologically active miniproteins.
Main Results:
- Established methodologies for de novo miniprotein design.
- Successful construction of miniproteins targeting difficult protein classes.
- Demonstrated potential for developing novel therapeutics.
Conclusions:
- Miniproteins represent a powerful platform for drug discovery.
- Advancements in design and synthesis are enabling the targeting of undruggable proteins.
- This field holds significant promise for future therapeutic interventions.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Protein-protein Interfaces
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...